Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Merck (MRK) - Get Report : "I think Merck has the best anti-cancer portfolio and I'll bless buying more."

Cara Therapeutics (CARA) - Get Report : "I think it's really good. Buy, buy, buy."

Yirendai (YRD) - Get Report : "I'm sorry, this is a sell. I only recommend (BIDU) - Get Report and Alibaba (BABA) - Get Report ."

IBM (IBM) - Get Report : "I think it will be an OK quarter. I'd buy some here and some more lower."

FactSet Research Systems (FDS) - Get Report : "I like that stock."

Annaly Capital (NLY) - Get Report : "I find this one very opaque and I can't recommend it."

Smart Global Holdings (SGH) - Get Report : "My favorite is HP (HPQ) - Get Report . I'd go with that one."

PPG Industries (PPG) - Get Report : "Accounting irregularities equals sell and I can't go against my rules."

Cramer and the AAP team are making a few more updates to the bullpen: Johnson and Johnson (JNJ) - Get Report , Clorox (CLX) - Get Report , and Procter & Gamble (PG) - Get Report . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Over on Real Money, Cramer says it's not too late to buy oil companies that are spending to find more petroleum -- and servicers like Schlumberger (SLB) - Get Report that are also set to benefit. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in SLB.